Previous Close | 66.02 |
Open | 0.00 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's Range | 66.02 - 66.02 |
52 Week Range | 66.02 - 66.02 |
Volume | |
Avg. Volume | N/A |
Market Cap | N/A |
Beta (5Y Monthly) | 0.19 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Haleon, a global leader in consumer health, today announced the appointment of Christine Jakovcic as General Manager, Haleon Canada. This appointment follows Rupa Bahri stepping down after a distinguished 13-year career with the company to pursue other interests. Over the past six years, Rupa's leadership has been pivotal in elevating the Canadian business, achieving exceptional growth, and nurturing an inclusive, engaged company culture.
Eroxon®, the first-and-only FDA cleared gel available without a prescription for the treatment of erectile dysfunction (ED), is now available for pre-order in the United States through Amazon and will be available at most major retailers in October 2024.
HYDERABAD, India, June 26, 2024--Dr. Reddy’s to acquire Nicotinell and related portfolio in significant step towards building global consumer healthcare business